Here is a list of resources on the diagnosis and management of liver diseases.
- Non-Invasive Liver Disease Assessment from the American Association For The Study Of Liver Diseases
- Practice Guidelines from the American Association For The Study Of Liver Diseases
- New MASLD Nomenclature from the American Association For The Study Of Liver Diseases
- “No more NAFLD! Steatotic Liver Disease is the overarching term; NAFLD is now MASLD.”
- Dig Deeper!
- Diagnosis and Management of Cirrhosis and Its Complications: A Review [PubMed Abstract] [Full-Text HTML] [Full-Text PDF]. JAMA. 2023 May 9;329(18):1589-1602. doi: 10.1001/jama.2023.5997.
- Hepatitis B Management: Guidance For The Primary Care Provider. Last updated Feb 25, 2020.
- Hepatitis A from StatPearls. Natalya Iorio; Savio John. Last Update: July 4, 2023.
- Hepatitis B from StatPearls. Nishant Tripathi; Omar Y. Mousa. Last Update: July 9, 2023.
- Autoimmune Hepatitis from StatPearls. Catherine D. Linzay; Bashar Sharma; Sudha Pandit. Last Update: August 14, 2023.
- Autoimmune Hepatitis and Pregnancy from StatPearls. Jiten P. Kothadia; Jamil M. Shah. Last Update: February 6, 2023.
- Autoimmune Hepatitis from LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. [Full-Text HTML] [Full-Text PDF]. Updated: May 4, 2019.
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. LiverTox Database Updated: 13 May 2024.
- “LiverTox® provides up-to-date, unbiased and easily accessed information on the diagnosis, cause, frequency, clinical patterns and management of liver injury attributable to prescription and nonprescription medications and selected herbal and dietary supplements. The LiverTox site is meant as a resource for both physicians and patients as well as for clinical academicians and researchers who specialize in idiosyncratic drug induced hepatotoxicity.”
